JelloX Biotech
Founded 2018
About JelloX Biotech
Our automated 3D histopathology platform generates comprehensive pathologic images in support of quantitative data analyses and standardized digital format to overcome technology limitation of current 2D image diagnosis tools. The platform offers an innovative optical tissue clearing immersion system with high-resolution of 3D image technology, employing alternative scanning and slicing processes reliable depth control of continuous automatic images and digital parallel multi-stack images, and panoramic 3D digital images of a complete histopathological sample are produced. The platform thus allows detection in-depth and comparative analysis of normal and pathological organization. Moreover, our innovative database stores high resolution images of deep tissues suitable for building up artificial intelligence analysis, improving healthcare quality, accuracy and efficiency, and playing an indispensable link for precision medicine.
Company Facts
- Founded: 2018
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Website: jellox.com
- Phone: 03 6583058
Social Profiles
Canonical: https://fsome.com/organization/jellox-biotech-8277047 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.